Cancer

News

Early data from Roche's NHL drug mosunetuzumab steals the sh...

There’s been a slew of scientific data coming from the American Society for Hematology (ASH) conference, but promising early data from Roche’s mosunetuzumab proved to be one of the major ta

News

Sanofi snaps up Synthorx for $2.5bn, eyeing cancer immunothe...

Sanofi has agreed to buy cancer drugs firm Synthorx for around $2.5 billion, aiming to strengthen its immune-oncology drug pipeline and creating the possibility of new combination therapies

News

App helps cancer patients manage their meds

A healthcare app due to launch at the end of this year aims to empower cancer patients and improve survival outcomes by allowing patients to better manage their medications and care.

News

FDA grants AZ's Imfinzi fast review in new lung cancer use

The FDA has granted AstraZeneca’s Imfinzi immunotherapy a faster six-month review in patients with extensive-stage small cell lung cancer.

Events

HW191105 World ADC London banner design 740 X 400px

Partner Content

World ADC London 2020

Maximise the Therapeutic Index of Your ADC Pipeline

News

Merck & Co's Keytruda shows promise with prostate cancer 'su...

A small proportion of men with advanced prostate cancer, who have exhausted all other treatment options, were ‘super responders’ to Merck & Co’s Keytruda (pembrolizumab) immunotherapy i

Early data from Roche's NHL drug mosunetuzumab steals the sh...

Sanofi snaps up Synthorx for $2.5bn, eyeing cancer immunothe...

App helps cancer patients manage their meds

FDA grants AZ's Imfinzi fast review in new lung cancer use

World ADC London 2020

Merck & Co's Keytruda shows promise with prostate cancer 'su...

Dexcom is first to join FDA/CMS health tech pilot

Discover a new era of healthcare panel engagement: Grounded ...

Cancer

Editor's Picks